Horny goat weed

Note: This advice is given by the CAP Executive about non-broadcast advertising. It does not constitute legal advice. It does not bind CAP, CAP advisory panels or the Advertising Standards Authority.

Horny Goat Weed is the generic or common name for a medicinal herb traditionally used as an aphrodisiac. Its botanical name is Epimedium sagittatum. To date, neither CAP nor the ASA has seen evidence to prove that it has such an effect and marketers wanting to advertise the product should do so on an availability-only platform; they should make no direct or implied claims about its purported aphrodisiac effect.

Furthermore, the Medicines and Healthcare product Regulatory Agency (MHRA) has stated that Epimedium sagitattum is known to have medicinal uses and including it in a product may well lead to the product being classified as a medicine. Claims that the herb might rectify flagging sexual function might also render the product medicinal by presentation. Medicinal claims are those that suggest the product can treat or prevent a disease or restore, correct or modify physiological functions in human beings, as well as those that refer to interference with the normal operation of physiological function. If the MHRA classes a product as medicinal, either by function or presentation, advertisers need to obtain a marketing authorisation from the MHRA before selling that product in the UK (Rule 12.11). Marketers that are unsure can talk to the Borderline Section at the MHRA or check on the Agency’s website at www.mhra.gov.uk under Borderline/How the MHRA determines whether a product is medicinal.

If a product name amounts to an implied claim, CAP generally asks marketers either to change the name of the product or to include a disclaimer explaining that the implied effect is unproven (see ‘Claims in Names). Marketers are, however, allowed to use the generic name and the MHRA has disapproved of the inclusion of a disclaimer along the lines of “This product is not a proven aphrodisiac”. CAP therefore advises marketers to include a less specific disclaimer, one that does not refer to sexual stamina or performance, for example “The efficacy of this product has not been proven” or “This product has not been proven to work”.

Last modified : 30 July 2010

AdviceOnline Database

Sign up

Keep up-to-date with the latest news and advice on how to comply with the rules

Sign up

Already registered? Log in

Request Bespoke Copy Advice

From free single issues enquiries, through to premium services such as ultra-fast turnaround response enquiries and full Website Audits, the Copy Advice team can fulfill all of your compliance advice needs.

Request Bespoke Advice

Watch Digital advertising webcast

Watch the recording of the Digital remit training seminar. All you have to do is login or sign up to CAP Services if you are not already a registered user.

Watch Digital webcast

Watch new Advertising Codes seminar

Watch the recording of one of the General Overview of the new Advertising Codes training seminar. All you have to do is login or sign up to CAP Services if you are not already a registered user.

Watch webcast

Help notes

Comprehensive guide to the interpretation of the rules on a sector or issue.

Help Notes

FAQs

Have you got any questions about Copy Advice? Here are some frequently asked questions about the service provide.

Visit FAQs section

Committee of Advertising Practice Ltd, Mid City Place, 71 High Holborn, London WC1V 6QT  |  Copyright © 2012 CAP